(Circulation. 2001;103:38.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction
Data From the National Registry of Myocardial Infarction 3
From the Ahmanson-UCLA Cardiomyopathy Center (G.C.F.), UCLA Division of Cardiology, and the Harbor-UCLA Medical Center (W.J.F.), Los Angeles, Calif, and the Cardiovascular Outcomes Research Center (L.S.P., H.S., J.A.M.), University of Washington.
Correspondence to Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, 10833 Le Conte Ave, Los Angeles, CA 90095-1679. E-mail gfonarow{at}mednet.ucla.edu
Background—The present study aimed to assess use of lipid-lowering medication at discharge in a current national sample of patients hospitalized with acute myocardial infarction and to evaluate factors associated with prescribing patterns.
Methods and Results—Demographic, procedural, and discharge medication data were collected from 138 001 patients with acute myocardial infarction discharged from 1470 US hospitals participating in the National Registry of Myocardial Infarction 3 from July 1998 to June 1999. Lipid-lowering medications were part of the discharge regimen in 31.7%. Among patients with prior history of CAD, revascularization, or diabetes, less than one half of the patients were discharged on treatment. In multivariate analysis, factors independently related to lipid-lowering use included history of hypercholesterolemia (odds ratio [OR] 4.93; 95% CI 4.79 to 5.07), cardiac catheterization during hospitalization (OR 1.29; 95% CI 1.24 to 1.34), care provided at a teaching hospital, (OR 1.26; 95% CI 1.22 to 1.32), use of ß-blocker (OR 1.43; 95% CI 1.39 to 1.48), and smoking cessation counseling (OR 1.51; 95% CI 1.44 to 1.59). Lipid-lowering medications were given less often to patients who were older (65 to 74 versus <55 years of age; OR 0.82; 95% CI 0.78 to 0.86), those with a history of hypertension (OR 0.92; 95% CI 0.89 to 0.95), and those undergoing coronary artery bypass graft surgery (OR 0.58; 95% CI 0.55 to 0.60).
Conclusions—Analysis of current practice patterns for the use of lipid-lowering medications in patients hospitalized with acute myocardial infarction reveals that a significant proportion of high-risk patients did not receive treatment at time of discharge.
Key Words: myocardial infarction • risk factors • hypercholesterolemia • lipids
This article has been cited by other articles:
 |
|
 |
|
  K. I. Paraskevas Applications of statins in cardiothoracic surgery: more than just lipid-lowering Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 377 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Afilalo, G. Duque, R. Steele, J. W. Jukema, A. J.M. de Craen, and M. J. Eisenberg Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 37 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Kikano and M. T. Brown Antiplatelet Therapy for Atherothrombotic Disease: An Update for the Primary Care Physician Mayo Clin. Proc., May 1, 2007; 82(5): 583 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tricoci, M. T. Roe, and E. D. Peterson Clopidogrel in Patients With Acute Coronary Syndromes: Learning From Clinical Practice--Reply Arch Intern Med, November 13, 2006; 166(20): 2293 - 2293. [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Ray, R. G. Bach, C. P. Cannon, R. Cairns, A. J. Kirtane, S. D. Wiviott, C. H. McCabe, E. Braunwald, C. M. Gibson, and for the PROVE IT-TIMI 22 Investigators Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS Eur. Heart J., October 1, 2006; 27(19): 2310 - 2316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon, B. A. Steinberg, S. A. Murphy, J. L. Mega, and E. Braunwald Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy J. Am. Coll. Cardiol., August 1, 2006; 48(3): 438 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Newby, N. M. Allen LaPointe, A. Y. Chen, J. M. Kramer, B. G. Hammill, E. R. DeLong, L. H. Muhlbaier, and R. M. Califf Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease Circulation, January 17, 2006; 113(2): 203 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Diamantopoulos, V. G. Athyros, G. K. Yfanti, E. N. Migdalis, M. Elisaf, P. E. Vardas, A. S. Manolis, D. T. Karamitsos, E. S. Ganotakis, D. Hatseras, et al. The contrOL of dYslipideMia in outPatIent clinics in GreeCe (Olympic) Study Angiology, November 1, 2005; 56(6): 731 - 741. [Abstract] [PDF]
|
|
|
|
|
|
C. Ballantyne, B. Arroll, and J. Shepherd Lipids and CVD management: towards a global consensus Eur. Heart J., November 1, 2005; 26(21): 2224 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bittner Perspectives on Dyslipidemia and Coronary Heart Disease in Women J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1628 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Jaber, R. J. Lennon, V. Mathew, D. R. Holmes Jr, A. Lerman, and C. S. Rihal Application of Evidence-Based Medical Therapy Is Associated With Improved Outcomes After Percutaneous Coronary Intervention and Is a Valid Quality Indicator J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1473 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Neumann, A. B. Rosen, and M. C. Weinstein Medicare and Cost-Effectiveness Analysis N. Engl. J. Med., October 6, 2005; 353(14): 1516 - 1522. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Khanderia, K. A. Townsend, K. Eagle, and R. Prager Statin Initiation Following Coronary Artery Bypass Grafting: Outcome of a Hospital Discharge Protocol Chest, February 1, 2005; 127(2): 455 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Olson, J. Rasmussen, B. G. Sandhoff, J. A. Merenich, and for the Clinical Pharmacy Cardiac Risk Service (CP Lipid Management in Patients With Coronary Artery Disease by a Clinical Pharmacy Service in a Group Model Health Maintenance Organization Arch Intern Med, January 10, 2005; 165(1): 49 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Betancourt, R. B. Van Stavern, D. Share, P. Gardella, M. Martus, and S. Chaturvedi Are patients receiving maximal medical therapy following carotid endarterectomy? Neurology, December 14, 2004; 63(11): 2011 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lavie and R. Milani Benefits of Cardiac Rehabilitation in the Elderly Chest, October 1, 2004; 126(4): 1010 - 1012. [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Scott, C. P. Denaro, A. C. Hickey, C. Bennett, A. M. Mudge, D. C. Sanders, J. Thiele, and J. L. Flores Optimising care of acute coronary syndromes in three Australian hospitals Int. J. Qual. Health Care, August 1, 2004; 16(4): 275 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.D. Waters and K.K. Khush Management of the acute coronary syndrome patient Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C49 - C57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ben-Yehuda The cardiologist's toolbox: improving care J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2174 - 2176. [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Ko, M. Mamdani, and D. A. Alter Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients: The Treatment-Risk Paradox JAMA, April 21, 2004; 291(15): 1864 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. LaBresh, A. G. Ellrodt, R. Gliklich, J. Liljestrand, and R. Peto Get With the Guidelines for Cardiovascular Secondary Prevention: Pilot Results Arch Intern Med, January 26, 2004; 164(2): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Athyros, A. A. Papageorgiou, A. N. Symeonidis, T. P. Didangelos, A. N. Pehlivanidis, V. I. Bouloukos, and D. P. Mikhailidis Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus: A Subgroup Analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study Angiology, November 1, 2003; 54(6): 679 - 690. [Abstract] [PDF]
|
|
|
|
 |
|
 L. L. Carr Summary of the Role of Statins in the Treatment of Dyslipidemia J Am Osteopath Assoc, July 1, 2003; 103(7_suppl_3): S1 - S3. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow The Challenge of Balancing Scientific Discovery and Translation Circulation, January 28, 2003; 107(3): 358 - 362. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lalouschek, W. Lang, S. Greisenegger, and M. Mullner Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack Stroke, January 1, 2003; 34(1): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Muntwyler, G. Abetel, C. Gruner, and F. Follath One-year mortality among unselected outpatients with heart failure Eur. Heart J., December 1, 2002; 23(23): 1861 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rahimtoola Bilateral internal mammary artery grafting for coronary artery bypass grafting: why men versus women? Ann. Thorac. Surg., November 1, 2002; 74(5): 1435 - 1437. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Wright, J. G. Murphy, K. A. Bybee, S. L. Kopecky, and J.-M. LaBlanche Statin Lipid-Lowering Therapy for Acute Myocardial Infarction and Unstable Angina: Efficacy and Mechanism of Benefit Mayo Clin. Proc., October 1, 2002; 77(10): 1085 - 1092. [Abstract] [PDF]
|
|
|
|
 |
|
 L Wei, J Wang, P Thompson, S Wong, A D Struthers, and T M MacDonald Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study Heart, September 1, 2002; 88(3): 229 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Benjamin, S. C. Smith Jr, R. S. Cooper, M. N. Hill, and R. V. Luepker Task Force #1--magnitude of the prevention problem: opportunities and challenges J. Am. Coll. Cardiol., August 21, 2002; 40(4): 588 - 603. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Ades, T. E. Kottke, N. Houston Miller, J. C. McGrath, N. B. Record, and S. S. Record Task Force #3--getting results: who, where, and how? J. Am. Coll. Cardiol., August 21, 2002; 40(4): 615 - 630. [Full Text] [PDF]
|
|
|
|
 |
|
 G. C Fonarow Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis Vascular Medicine, August 1, 2002; 7(3): 187 - 194. [Abstract] [PDF]
|
|
|
|
|
|
C G Isles Patients with acute coronary syndrome should start a statin while still in hospital Heart, July 1, 2002; 88(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
|
|
P G Steg, B Iung, L J Feldman, D Cokkinos, J Deckers, K A A Fox, U Keil, and A P Maggioni Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes Heart, July 1, 2002; 88(1): 20 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yarzebski, C. F. Bujor, R. J. Goldberg, F. Spencer, D. Lessard, and J. M. Gore A Community-Wide Survey of Physician Practices and Attitudes Toward Cholesterol Management in Patients With Recent Acute Myocardial Infarction Arch Intern Med, April 8, 2002; 162(7): 797 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Lacy, D.-C. Suh, J. A. Barone, M. Bueno, D. Moylan, C. Swartz, R. V. Kudipudi, and J. B. Kostis Impact of a Targeted Intervention on Lipid-Lowering Therapy in Patients With Coronary Artery Disease in the Hospital Setting Arch Intern Med, February 25, 2002; 162(4): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Zebrack, J. B. Muhlestein, B. D. Horne, J. L. Anderson, and Intermountain Heart Collaboration Study Group C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina J. Am. Coll. Cardiol., February 20, 2002; 39(4): 632 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Vorchheimer and V. Fuster Inflammatory Markers in Coronary Artery Disease: Let Prevention Douse the Flames JAMA, November 7, 2001; 286(17): 2154 - 2156. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Beller Presidential address: quality of cardiovascular care in the U.S. J. Am. Coll. Cardiol., September 1, 2001; 38(3): 587 - 594. [Full Text] [PDF]
|
|
|
|
|
|
G. C. Fonarow and C. M. Ballantyne In-Hospital Initiation of Lipid-Lowering Therapy for Patients With Coronary Heart Disease : The Time Is Now Circulation, June 12, 2001; 103(23): 2768 - 2770. [Full Text] [PDF]
|
|
|
|
|
|
F. M. Sacks Lipid-Lowering Therapy in Acute Coronary Syndromes JAMA, April 4, 2001; 285(13): 1758 - 1760. [Full Text] [PDF]
|
|